Symptomatic Botulism caused by Clostridium botulinum serotype A
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB13900 | Equine Botulinum Neurotoxin A Immune FAB2 | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB13900 | Equine Botulinum Neurotoxin A Immune FAB2 | Botulinum neurotoxin type A | target |
| Drug | Drug Name | Phase | Status | Count |
|---|